High-affinity antibodies against calmodulin (CaM)-dependent cyclic nucleotide phosphodiesterase and protein phosphatase (calcineurin) were purified and characterized. Rabbit anti-phosphodiesterase antibody did not react with other phosphodiesterases or with the regulatory subunits of cAMP-dependent protein kinase. Affinity-puriflied goat anti-calcineurin antibody recognized both the 61-kDa catalytic subunit and the 18-kDa Ca2+-binding subunit of the phosphatase. Neither antibody reacted with CaM, several CaM-binding proteins (calmodulin-dependent protein kinase, myosin light chain kinase, fodrin), or other cytosolic proteins from brain. The antibodies were used to compare the cellular localization of these two CaM-dependent enzymes in rat brain. Both calcineurin and phosphodiesterase were found predominantly in nerve cells; however, phosphodiesterase was restricted to very specific neuronal populations. Phosphodiesterase was prominent in the somatic cytoplasm and dendrites of regional output neurons-e.g., cerebellar Purki je cells and hippocampal and cortical pyramidal cells. The extensive and uniform staining in the dendrites was consistent with postsynaptic localization and suggested an important function for this enzyme in neurons that integrate multiple convergent inputs. Calcineurin was present in virtually all classes of neurons, with immunoreactivity confined primarily to cell bodies. Both diffuse cytoplasmic staining and characteristic punctate staining of cell bodies were observed; the latter suggested compartmentalization of calcineurin at or near the plasma membrane. The results of this study demonstrate that calcineurin and phosphodiesterase are differentially localized in the central nervous system. Thus, the expression and compartmentalization of CaM-binding proteins may be highly regulated and specific for particular differentiated nerve cell types.
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Our understanding of cyclic nucleotide and phosphoprotein metabolism relies heavily upon in vitro studies of enzymes isolated from specific tissues. However, without concomitant knowledge of their regional and subcellular distribution, the physiologic functions subserved by these enzymes are difficult to assess. It is known that cyclic nucleotide metabolism is important in mediating hormone-dependent cellular events in many tissues (1) and is thought to be involved in adrenergic neurotransmission in the central nervous system (2) and photoreception in mammalian rod outer segment (3) . Interestingly, both the synthetic and degradative enzymes for cAMP metabolism have their highest specific activities in brain and are positively modulated by Ca2" through the Ca2+-binding protein calmodulin (CaM) (4, 5) . These facts suggest important and interactive roles for Ca2l and cAMPregulated systems in the function of nerve cells (6) .
Perhaps equally important in control of nerve cell activity is the state of protein phosphorylation, which reflects the activities of several species of protein kinase and phosphatase (7, 8) . Of particular interest has been the involvement of the CaM-dependent kinases and their putative substrates in neurotransmission. Increases in the activity of this enzyme have been correlated with increased electrical activity (9) , and the kinase appears to be highly concentrated in synaptosomal preparations and postsynaptic densities (10, 11) . Furthermore, it has now been established that a major CaM-binding protein in brain, calcineurin (12) , is itself a protein phosphatase (13) , suggesting that protein dephosphorylation is an important function controlled by Ca2".
While the preferred phosphoprotein substrate of this enzyme is not yet known, several neuron-specific proteins can serve as substrates of this enzyme (14) .
It is tempting to speculate that Ca2+/CaM, cyclic nucleotides, and protein phosphorylation may interact in a concerted fashion to modulate neuronal activity. However, to support such a hypothesis, it is necessary to document and compare the regional and subcellular localizations of such enzymes in nerve cells-i.e., are the CaM-dependent enzymes of cyclic nucleotide and phosphoprotein metabolism coordinately expressed in the same neurons or are they distributed in different populations of nerve cells? Since Ca2'-dependent events might vary greatly for different neurons, it is possible that only specific enzyme activities may be expressed in a particular differentiated cell type.
We have investigated these alternatives by using immunocytochemical localization ofphosphodiesterase and calcineurin with high-affinity antibodies specific for these enzymes. These antibodies show no cross-reactivity with proteins of related function (i.e., CaM-binding proteins, phosphodiesterases) or with other cystosolic brain proteins. The present report compares the distribution of these proteins in brain and discusses their patterns of localization with regard to potential functional roles for these enzymes in the central nervous system. § METHODS Purification of CaM-Binding Proteins. Phosphodiesterase and calcineurin were purified to homogeneity from bovine brain as previously described (15 An adult female goat was injected subcutaneously with purified calcineurin (1 mg in complete Freund's adjuvant) and thereafter with 1 mg in incomplete adjuvant at 30-to 40-day intervals. The animal was subjected to plasmaphoresis 7-10 days after injection and the plasma was stored at 4°C.
Portions of the goat plasma (350 ml) were incubated overnight with 10 ml of calcineurin-Sepharose 4B (2 mg of protein per ml of gel) (16) with gentle mixing, after which the gel was transferred to a column (2.5 cm diameter). After washing with 60 ml of buffer A, the column was eluted with buffer B into a tube containing 0.1 bed volume of 2 M Tris, pH 9, and mixed. The eluate was chromatographed on a column of protein A-Sepharose (4 mg of eluted protein per ml of gel), as described above for phosphodiesterase antibody. This protein A eluate of affinity-purified antibody was used as the anti-calcineurin antibody.
Sodium Dodecyl Sulfate Electrophoresis and Immunoblot ("Western Blot") Procedures. Samples of protein (2-30 jig)
were solubilized in buffer containing sodium dodecyl sulfate and electrophoresed on small polyacrylamide gels prepared as described (17) . After transfer to nitrocellulose (100 V, 1.5 hr) (18), the sections were stained (1 min) for adsorbed protein with amido black, allowed to react with biotinylated CaM (19) , or incubated with antibody as described below. Nitrocellulose sections were placed in blocking solution (5% nonfat dry milk in Tris-buffered saline (TBS) containing 0.02% thimerosal) for 30 min, after which they were incubated (4 hr, 25°C) with primary antibody diluted in blocking solution. After washing with TBS, the sections were incubated (1.5 hr, 25°C) with alkaline phosphatase-labeled antibody diluted in blocking solution (16) . For phosphodiesterase, the detecting antibody was goat anti-rabbit (Promega Biotec, Madison, WI), while for calcineurin, it was rabbit anti-goat (Kirkegaard and Perry, Gaithersburg, MD). Phosphatase-labeled antibody was detected by using reagents and conditions specified by the supplier (Promega Biotec). All reagents used for electrophoresis and immunoblotting procedures were from Bio-Rad.
Immunohistochemical Procedures. Adult male Long-Evans and Sprague-Dawley rats were perfused transcardially while they were under deep pentobarbital anesthesia (Nembutal at 50 mg/kg; i.p.) with phosphate-buffered saline (PBS; 0.9% NaCl in 50 mM sodium phosphate buffer, pH 7.4), followed by 50 mM sodium phosphate buffer containing 10% Formalin. After incubation overnight in the perfusion fixative (4°C), the brains were transferred to cold PBS, and 50-to 100-gm sections were cut on a Vibratome (Oxford). The sections were washed with cold PBS and incubated at 4°C with primary antibody or preimmune serum, diluted 1:500 in PBS containing 0.5% Triton X-100 (TPBS) and either 1% normal goat serum (calcineurin) or 1% normal rabbit serum (phosphodiesterase); sections then were rinsed with at least three changes of TPBS for 20-30 min per wash.
For anti-phosphodiesterase, the sections were incubated at room temperature for 1 hr with biotinylated affinity-purified goat anti-rabbit IgG (Vector Laboratories, Burlingame, CA) diluted 1:50 in TPBS. For anti-calcineurin, the same incubation conditions were used, except that a biotinylated affinitypurified rabbit anti-goat IgG was used as a second antibody. All sections were washed three times in PBS, followed by incubation for 1 hr with avidin-horseradish peroxidase conjugate (ABC reagent, Vector Laboratories) in PBS. After washing, the sections were allowed to react with diaminobenzidine substrate (50 mg/100 ml of PBS, containing 0.03% H202) for 5 min, rinsed in PBS, and mounted on chrome alum/gelatin-coated slides. Slides were dried overnight, then dehydrated through a graded alcohol series [two changes each of 70%, 95%, and 100% (vol/vol) ethanol], cleared in three changes of xylene, and coverslipped with a synthetic medium (Permount, Fisher Scientific). Photomicrographs were taken with Kodak ASA 25 technical pan film with a green filter.
RESULTS
Characterization and Specificity of Antibodies. Antisera against bovine brain CaM-dependent cyclic nucleotide phosphodiesterase and protein phosphatase (calcineurin) were further purified by affinity chromatography on protein A-Sepharose and, in the case of calcineurin, by using antigen coupled to CNBr-activated Sepharose (see Methods). Phosphodiesterase antibody did not react with rod outer segment phosphodiesterase, purified liver cyclic nucleotidestimulated phosphodiesterase, or the regulatory subunits of cAMP-dependent protein kinase (data not shown). Antiphosphodiesterase antibody detected the 60-kDa peptide of the brain enzyme but did not react with other brain CaMbinding proteins (e.g., CaM-dependent protein kinase, fodrin, caldesmon, calcineurin) or with other proteins from whole brain supernatant (Fig. 1A) . [A faint immunoreactive peptide of approximately 70 kDa was observed in some immunoblots. This may represent a slightly larger form of the brain CaM-activated enzyme, which has been described (20) .]
The affinity-purified calcineurin antibody recognized both the 61-and 18-kDa subunits of the purified phosphatase and did not react with phosphodiesterase (Fig. 1B) , other CaMbinding proteins, or other proteins from brain cytosol. Solidphase immunoassays with immobilized calcineurin and phosphodiesterase showed no significant cross-reactivity of either antibody at dilutions of 1:200 or less (data provided to reviewers). The antibodies detected as little as 5 ng of phosphodiesterase or 10 ng of calcineurin present in blots of crude samples.O Since the specificity and sensitivity of these antibodies had been established, comparison of the localization of these two enzymes in rat brain sections was carried out. Preimmune sera did not react with brain sections.
Neuronal Distribution of Phosphodiesterase and Calcineurin in Rat Brain. The number and pattern of cells immunoreactive for phosphodiesterase or calcineurin were quite different. Although both enzymes appeared to be absent from nonneuronal cell types, calcineurin was distributed widely, while only specific neuronal populations reacted with antibodies against phosphodiesterase. In some areas, the difference in immunoreactivity with these two enzymes was virtually all-or-none. For example, calcineurin immunoreactivity in hypothalamus was seen in all neurons of the paraventricular nucleus and adjacent structures (Fig. 2) .
SThe 18-kDa Ca2"-binding subunit of calcineurin (12) This indicated differential expression of these two CaMdependent proteins in some neurons.
Although unreactive in many brain regions, the phosphodiesterase antibody produced intense immunoreactivity in specific populations of neurons in the neocortex (Fig. 3A) , hippocampal formation (Fig. 3B) , and cerebellar cortex (Fig.  3C) . Phosphodiesterase was prominent in large pyramidal cells of the neocortex, the hippocampus, and Purkinje cells in the cerebellum; other nerve cell populations associated with these structures (e.g., cerebellar granule cells or basket cells) were unreactive. Furthermore, there was no significant staining ofthe many neurons (or axons) that impinge on these neuron populations. Characteristic of the immunoreactivity of these large cell types was the extensive staining produced in their dendritic fields (Fig. 3) , although it was not observed at the level of dendritic spines (data not shown). Substantial reactivity also was associated with somata of these neurons, but axons showed no staining.
Calcineurin, on the other hand, appeared to be a marker for neurons in general, with the substantia nigra, corpus striatum, cerebral cortex, and hippocampus exhibiting the highest amounts ofimmunoreactivity. Areas such as cerebral cortex, which showed phosphodiesterase staining only in selected layers (III, V, VI), were uniformly reactive with calcineurin antibodies (data provided to reviewers). In contrast to the pattern seen for phosphodiesterase, immunoreactivity in all regions was characterized by dense punctate staining of the cell bodies, with little reaction in dendritic fields. Staining of the neuropil was observed in some regions, although it was weak compared to that seen in neuronal somata.
Differences in Calcineurin and Phosphodiesterase Cellular
Localization. Striking differences in the cellular reactivity of calcineurin and phosphodiesterase were noted when viewed under higher magnification (oil-immersion optics). Photomicrographs of anti-phosphodiesterase reactivity suggested a relatively homogenous distribution in Purkinje cell somata and dendrites (Fig. 4A) . The reaction product seen with the calcineurin antibody, though, was of two types; part of the immunoreactivity was uniformly distributed in the soma, while another was concentrated in small, dense deposits (Fig.  4B ). This type of punctate immunoreactivity, which was often observed along the periphery of the cell body, is suggestive of a membrane association. This general pattern of staining also was observed in pyramidal cells of both the cerebral cortex and the hippocampus as well as cells in the corpus striatum. While occasional anti-calcineurin reactivity was seen in dendrites, this was usually found in regions just proximal to the cell body. It Phosphodiesterase, while it certainly may be expressed at low levels in many neurons, is present in highest concentrations in the soma and dendrites of certain nerve cells." The major phosphodiesterase-positive cell classes in the neocortex (layer III, V, and VI neurons), hippocampus (CA1 pyramidal cells), and cerebellar cortex (Purkinje cells) are all output neurons of their respective brain regions (32) (33) (34) . It is of interest that both CA1 pyramidal cells (35, 36) and cerebellar Purkinje cells (37) display Ca2"-dependent re-Neurobiology: Kincaid et al.
Ca2+/CaM activation ofphosphodiesterase (i.e., degradation of cyclic nucleotides) may play an important role in synaptic integration in these neurons. It should be noted that many neurons that exhibit Ca2"-dependent activity appear to have low amounts of phosphodiesterase; hence, additional factors appear to be necessary to elicit maximal expression of the enzyme.
Cyclic nucleotide regulation has been implicated as a correlate of electrogenic behavior of these classes of output neurons. Treatment of cerebellar slices with a variety of depolarizing agents produced a marked increase in cAMP (39) , and microiontophoretic application of either cAMP or dibutyryl-cAMP depressed electrical activity of cerebellar Purkinje cells (3, 40) . Immunocytochemical localization of cAMP-dependent protein kinase subunits (41), cGMP-dependent protein kinase (42, 43) , and G-substrate (substrate for cGMP-dependent protein kinase) in Purkinje cells (27) further suggests a role for cyclic nucleotides in the mediation or sequelae of electrogenic events.
The high amounts of CaM-dependent phosphodiesterase in specific neurons might be compared to those of the lightactivated cGMP phosphodiesterase found in rod outer segment ofretina (44) . In the retina, photic, rather than synaptic, stimulation causes increased production of cyclic nucleotide, which is rapidly inactivated by the phosphodiesterase. In both cell types, high concentrations ofthe phosphodiesterase may be required to effectively regulate cAMP (or cGMP) concentrations, thereby modulating integration of signal input. Since the afferent fibers would determine the amount of signal to output neurons, one might expect that damage to these could alter phosphodiesterase activity. In fact, selective chemical destruction of climbing fiber input to Purkinje cells virtually eliminates phosphodiesterase immunoreactivity in the dendrites and somata of these cells (45) . This suggests that expression of brain phosphodiesterase in Purkinje cells is under transsynaptic regulation.
The basis for such selective production of phosphodiesterase is, of course, gene expression. Since only very few cells in brain express this enzyme in substantial amounts, the potential for expression may be very great and specific signals (e.g., synaptic activity) may dramatically increase the levels of this enzyme during neuronal development. Future studies on the regulation of this and other CaM-regulated enzymes may provide clues not only to control of gene expression but also perhaps to the process of nerve cell differentiation.
